Kogiso, Tomomi
Tokushige, Katsutoshi
Article History
Received: 2 October 2020
Accepted: 20 November 2020
First Online: 10 December 2020
Competing interests
: KT has received research funding from Sumitomo Dainippon Pharma Co., Ltd., Astellas Pharma Inc., Eisai Co., Ltd., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Pharmaceutical Co., Ltd., AbbVie GK, Takeda Pharmaceutical Co. Ltd., Asahi Kasei Corporation. Ajinomoto Co., Inc., and Otsuka Pharmaceutical Co., Ltd. TK; Nothing to declare.